Marc A. Ilies, PhD is a Professor in the Department of Pharmaceutical Sciences and a founding member of the Moulder Center for Drug Discovery Research at the Temple University School of Pharmacy in Philadelphia, PA, USA. His research interests lie in the broadly defined area of bio-organic and medicinal chemistry/chemical biology at membrane interfaces, where he combines heterocyclic chemistry and drug design, materials sciences and pharmaceutical sciences to generate novel therapeutic entities with a high therapeutic index.
Dr. Ilies' research group is active towards synthesis, self-assembling, physicochemical and biological properties of assemblies of amphiphilic molecules of different molecular weights and packing parameters (surfactants, gemini surfactants, lipophilic oligomeric surfactants, lipids, dendrons, polymers) and in their interfacial engineering for controlling the above-mentioned properties, drug and gene loading and delivery, enzymatic degradation and toxicity.
Dr. Ilies authored more than 85 publications, with over 4000 citations and an H index of 35. He teaches graduate-level courses in Biochemistry, Medicinal Chemistry and Advanced Drug and Gene Delivery Systems and he is a member of the editorial board of four peer-reviewed journals on these topics. He has chaired several sessions dedicated to different aspects related with the use of self-assembled systems in drug and nucleic acid delivery systems within the American Chemical Society's Division of Colloid and Surface Chemistry. He is also an active member of the American Association of Pharmaceutical Scientists, American Association of College of Pharmacy, American Society of Gene and Cell Therapy and Rho Chi Honor Society.
Dr. Ilies has a secondary appointment in the Alzheimer’s Center at the Temple University Lewis Katz School of Medicine and is a collaborating Member of the Fox Chase Cancer Center at Temple Health.